News & Perspective

Jul 19, 2019

Jul 19, 2019

ASP Scan (Weekly) for Jul 19, 2019

Stewardship survey results
Non-prescription antibiotic sales in Ethiopia
FDA approves new combo antibacterial
New Candida auris clade
Pharmacist review and antibiotic use
Rise in Candida auris cases
New AMR plan in Wales
Chinese probiotics

Oct 05, 2018

Oct 05, 2018

ASP Scan (Weekly) for Oct 05, 2018

MRSA de-colonization of therapy dogs
Multiple Candida auris introductions
Early stewardship interventions
Bacteriophage clinical trial
Improper antibiotic prescribing in China
Point-of-care flu tests and antibiotics
New tetracycline approved
Combo antibiotic for CRE
Telemedicine and antibiotic prescribing
FDA approves new antibiotic
Linezolid resistance in food animals
Water consumption and UTIs

Jan 12, 2018

Jan 12, 2018

News Scan for Jan 12, 2018

H7N9 death in China
Fluarix Quad for babies
Avian flu outbreaks
Vaccine-linked polio in DRC

Dec 12, 2016

Dec 12, 2016

Flu Scan for Dec 12, 2016

H7N9 cases in China
Avian flu in France, Finland
Generic Tamiflu

Jun 13, 2016

Jun 13, 2016

News Scan for Jun 13, 2016

Flour confirmed as E coli source
MCR-1 in Japan and Colombia
Chikungunya tops 2M cases

Apr 08, 2013

Apr 08, 2013

CDC waiting for H7N9 sample to speed test kits

(CIDRAP News) – A human isolate of the novel H7N9 influenza virus from China—needed for the development of diagnostic test kits and related efforts—is expected to arrive at the Centers for Disease Control and Prevention (CDC) within 2 days, a CDC official said today.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 18, 2005

Oct 18, 2005

Roche to build Tamiflu plant in US

(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it would build a plant in the United States to make oseltamivir (Tamiflu) and also consider licensing other companies to make the drug in the face of a possible flu pandemic.

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»